So, dacomitinib is this stuff that stops EGFR from doing its thing. It’s mainly used for lung cancer in people who have either an EGFR 19 exome deletion or the L858R mutation. It’s all about shutting down EGFR signaling.
You got three doses of this stuff: 15 mg, 30 mg, and 45 mg. The usual one they go for is 45 mg, once a day. These tablets have a coating and come in bottles with 30 of them in each.
